Literature DB >> 9852125

Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.

A K Swanson1, C M Stoltzfus.   

Abstract

Alternative splicing is used to generate more than 30 human immunodeficiency virus type 1 (HIV-1) spliced and unspliced mRNAs from a single primary transcript. The abundance of HIV-1 mRNAs is determined by the efficiencies with which its different 5' and 3' splice sites are used. Three splice sites (A4c, A4a, and A4b) are upstream of the rev initiator AUG. RNAs spliced at A4c, A4a, and A4b are used as mRNAs for Rev. Another 3' splice site (A5) is immediately downstream of the rev initiator. RNAs spliced at A5 are used as mRNAs for Env and Nef. In this report, primer extension analysis of splicing intermediates was used to show that there are eight branch points in this region, all of which map to adenosine residues. In addition, cis elements recognized by the cellular splicing machinery overlap; the two most 3' branch points overlap with the AG dinucleotides at rev 3' splice sites A4a and A4b. Competition of the overlapping cis sites for different splicing factors may play a role in maintaining the appropriate balance of mRNAs in HIV-1-infected cells. In support of this possibility, mutations at rev 3' splice site A4b AG dinucleotide dramatically increased splicing of the env/nef 3' splice site A5. This correlated with increased usage of the four most 3' branch points, which include those within the rev 3' splice site AG dinucleotides. Consistent with these results, analysis of a mutant in which three of the four env/nef branch points were inactivated indicated that use of splice site A5 was inhibited and splicing was shifted predominantly to the most 5' rev 3' splice site A4c with preferential use of the two most 5' branch points. Our results suggest that spliceosomes formed at rev A4a-4b, rev A4c, and env/nef A5 3' splice sites each recognize different subsets of the eight branch point sequences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852125     DOI: 10.1074/jbc.273.51.34551

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Identification of new and unusual rev and nef transcripts expressed by an HIV type 1 primary isolate.

Authors:  Yolanda Vega; Elena Delgado; Cristina Carrera; Paloma Nebreda; Aurora Fernández-García; María Teresa Cuevas; Lucía Pérez-Álvarez; Michael M Thomson
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-08       Impact factor: 2.205

2.  Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.

Authors:  S Jacquenet; D Ropers; P S Bilodeau; L Damier; A Mougin; C M Stoltzfus; C Branlant
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

3.  Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.

Authors:  P S Bilodeau; J K Domsic; C M Stoltzfus
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 4.  Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences.

Authors:  Nobubelo K Ngandu; Konrad Scheffler; Penny Moore; Zenda Woodman; Darren Martin; Cathal Seoighe
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

5.  Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform.

Authors:  Timothée Revil; Jordan Pelletier; Johanne Toutant; Alexandre Cloutier; Benoit Chabot
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

6.  Identification of new splice sites used for generation of rev transcripts in human immunodeficiency virus type 1 subtype C primary isolates.

Authors:  Elena Delgado; Cristina Carrera; Paloma Nebreda; Aurora Fernández-García; Milagros Pinilla; Valentina García; Lucía Pérez-Álvarez; Michael M Thomson
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

7.  The strength of the HIV-1 3' splice sites affects Rev function.

Authors:  Susanne Kammler; Marianne Otte; Ilona Hauber; Jørgen Kjems; Joachim Hauber; Heiner Schaal
Journal:  Retrovirology       Date:  2006-12-04       Impact factor: 4.602

8.  Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.

Authors:  Yolanda Vega; Elena Delgado; Jorge de la Barrera; Cristina Carrera; Ángel Zaballos; Isabel Cuesta; Ana Mariño; Antonio Ocampo; Celia Miralles; Sonia Pérez-Castro; Hortensia Álvarez; Isabel López-Miragaya; Elena García-Bodas; Francisco Díez-Fuertes; Michael M Thomson
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.